Clerkenwell Clinical Catalyst

Accelerating the future of mental health and CNS treatment.

Join our mission to bridge the gap between breakthrough CNS treatments and the people who desperately need them. Our Catalyst programme accelerates clinical development with expert-led workshops on clinical and regulatory strategy, 20% off specialist CRO services, grant support and access to our network of researchers and investors.

Applications are now closed, but we’re open to speculative applications—get in touch for future opportunities!

About the Programme

  • Clerkenwell Health exists to transform how clinical trials for pioneering CNS treatments are conducted and promoted. For smaller companies, advancing innovations often means navigating an industry that treats brain and mental health research as an afterthought. Traditional CRO support applies generic approaches that ignore the unique complexities of CNS and psychiatric populations, leaving innovators feeling underserved. This programme bridges that gap, offering select partners a collaboration designed to accelerate breakthrough treatments through our specialist, human-centred approach. 

    • Application deadline: 31st of January, 2025. 

    • Successful applicants announced: 15th of February, 2025

    • This programme is open to small to medium sized biotech, pharma and medtech companies focused on CNS and psychiatry - whether you’re just beginning clinical trials or advancing to later phases. 

    • Applications are welcome from companies worldwide. 

  • Step 1: Complete the application form by the 31st of January, 2025. It should take 5-10 minutes.

    Step 2: Wait for notification. Successful applicants will be contacted by the 15th of February, 2025. 

    • Applications will be reviewed by our team based on the alignment of your needs with our expertise, the potential impact of the partnership, and the commitment to collaboration. 

    • Finalists will be notified by the 15th of February, 2025.

    • Successful applicants will be invited to join our programme and will receive details on how to access the free workshop and other benefits. 

  • As part of this programme, selected participants will receive the following valuable benefits to support their clinical development efforts: 

    • Free Workshop: Access to a 90-minute tailored workshop focusing on clinical development, regulatory strategy, and clinical trial design in CNS and psychiatry. Led by our CSO Dr Henry Fisher and relevant experts from our scientific, regulatory, or commercial teams, this workshop offers actionable insights to design efficient and patient-centered trials.

    • Grant Support: Benefit from expert guidance for applications to leading grant programmes like Innovate UK, NIHR, and the Wellcome Trust. Our support includes budgeting, project design, and other essential aspects to help you secure funding and advance your research and development.

    • 20% Discount on CRO Services: You’ll receive a 20% discount on all our contract research organisation (CRO) services, ensuring you have the resources you need at a more accessible cost. 

    • Access to Our Network: You’ll also gain connections to our extensive network of specialised service providers, investors, key opinion leaders and leading researchers. This network can offer valuable collaboration opportunities and resources to further your clinical and business goals. 

    • Visibility & Exposure: Successful applicants will be featured on our website, gaining visibility among industry leaders and potential collaborators in the neuro space. 

Our Partnership Approach

We understand that every partnership has unique needs, especially in the complex world of CNS and psychiatry. Our approach combines rigorous science with compassionate collaboration. Here's what defines The Clerkenwell Health Way of partnership:

  • Aligned Incentives

    Your success is our success. We ensure that our priorities align with yours, measuring our achievements by the breakthrough treatments you bring to people who desperately need them.

  • Specialist Flexibility and Adaptability

    Our solutions are built around the unique demands of CNS research, not generic approaches. We're here to adapt and innovate with you, addressing the specific challenges of CNS clinical development. 

  • Direct access to CNS expertise

    Smaller companies deserve access to deep CNS specialisation. When you partner with us, you gain direct access to our team of six specialists with experience across 20+ CNS indications – the kind of focused expertise that transforms trials. 

  • Clear and Responsive Communication

    Every successful collaboration starts with understanding people's needs. We engage in open, consistent communication, ensuring we respond to your goals with the clarity and care that breakthrough science demands. 

Have questions?